Vitargent Biotechnology Overview
- Founded
- 2010

- Status
- Private
- Employees
- 5

- Latest Deal Type
- Series B2
- Investors
- 9
Vitargent Biotechnology General Information
Description
Provider of biotechnology and testing services. The company's biotechnology and testing services develops transgenic medaka and zebrafish fish embryo for conducting toxic laboratory tests, enabling industries such as cosmetics, skincare, food and beverage conglomerate to safeguard their products against harmful chemicals.
Contact Information
- Unit 203, 16 West
- Number 12 Science Park West Avenue
- Hong Kong, Hong Kong
- Hong Kong
Vitargent Biotechnology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series B2) | 04-Jul-2018 | Completed | Generating Revenue | |||
4. Later Stage VC (Series B1) | 01-Mar-2018 | 00000 | Completed | Generating Revenue | ||
3. Later Stage VC (Series B) | 26-May-2016 | Completed | Generating Revenue | |||
2. Early Stage VC (Series A) | 20-Jan-2015 | Completed | Startup | |||
1. Accelerator/Incubator | 15-Oct-2010 | Completed | Startup |
Vitargent Biotechnology Comparisons
Industry
00000000
000 000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialVitargent Biotechnology Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Eurofins Scientific | Corporation | Luxembourg, Luxembourg | 00000 | 00000 | 000000000 | 00000 |
000 000 0000000000 | Formerly PE-Backed | Saclay, France | 000 | 000000000000 | ||
0000000 0000000000 | Private Equity-Backed | Rensselaer, NY | 000 | 00.000 | 000000000 | 00.000 |
0000000 | Venture Capital-Backed | Riga, Latvia | 0 | 00000 | 0000000000 | 00000 |
0000000 | Private Equity-Backed | Ann Arbor, MI | 00000 | 0000000 0000 |
Vitargent Biotechnology Patents
Vitargent Biotechnology Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-201811234-D0 | Determination of safety grade or score of a product | Ceased | 09-Jul-2018 | 000000000 | |
EP-3594887-A1 | Computing system and method for determining safety index of product | Withdrawn | 09-Jul-2018 | 000000000 | 0 |
US-20200013133-A1 | Computing system and method for determining safety index of product | Pending | 09-Jul-2018 | 000000000 | |
EP-3255430-A1 | Toxicant assays for cosmetic products using teleost embryos | Granted | 08-Jun-2016 | 00000000000 | 0 |
EP-3255430-B1 | Toxicant assays for cosmetic products using teleost embryos | Active | 08-Jun-2016 | G01N33/5014 |
Vitargent Biotechnology Executive Team (5)
Vitargent Biotechnology Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Peter Liu | WI Harper Group | Chairman | 000 0000 |
Vitargent Biotechnology Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialVitargent Biotechnology Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Bridgefield Capital Management | PE/Buyout | Minority | 000 0000 | 000000 0 | |
HeungKong Group Limited | Corporation | Minority | 000 0000 | 000000 0 | |
Leohe Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
PwC China | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
Innoangel Fund | Venture Capital | Minority | 000 0000 | 000000 0 |